Cargando…

Assessment of Thrombophilic Abnormalities During the Active State of Inflammatory Bowel Disease

BACKGROUND/AIMS: Thromboembolic disease has been recognized as a complication of inflammatory bowel disease (IBD). The relative contributions of inherited or acquired thrombophilia and the inflammatory response to the mechanism of this tendency are unclear. Thrombotic events are more common in activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Maher, Maha M., Soloma, Somaya H.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702936/
https://www.ncbi.nlm.nih.gov/pubmed/19568537
http://dx.doi.org/10.4103/1319-3767.41743
_version_ 1782168816032153600
author Maher, Maha M.
Soloma, Somaya H.
author_facet Maher, Maha M.
Soloma, Somaya H.
author_sort Maher, Maha M.
collection PubMed
description BACKGROUND/AIMS: Thromboembolic disease has been recognized as a complication of inflammatory bowel disease (IBD). The relative contributions of inherited or acquired thrombophilia and the inflammatory response to the mechanism of this tendency are unclear. Thrombotic events are more common in active disease although significant numbers also occur spontaneously. The aim of this study was to investigate common thrombophilic markers in patients with active IBD. METHODS: Twenty-six patients with IBD who had active disease, and 40 sex- and age-matched non-IBD patients were recruited into the study. For all the subjects, complete blood counts, C-reactive protein levels, erythrocyte sedimentation rate, International normalized ratio, activated partial thromboplastin time, and levels of lupus anticoagulant, anticardiolipin antibodies (ACA IgG), proteins C and S, antithrombin-III (AT-III), and factor V were measured. RESULTS: The International normalized ratio, activated partial thromboplastin time, and levels of proteins C and S were comparable between the two groups. However, antithrombin-III levels were significantly lower in the IBD group as compared with that in the healthy control group (P < 0.001). ACA IgG was detected in one patient in the IBD group. Factor V Leiden mutation was present in 3.8% of the patients in the IBD group, whereas the prevalence was 2.5% in the control group. Significantly elevated platelet counts were observed in patients with active Crohn's disease compared with that in the control group (P < 0.001), but they were not significantly increased in active ulcerative colitis (P = 0.231). CONCLUSIONS: The present study failed to establish a strong association between the common thrombophilic markers and the active clinical course of IBD, with the exception of high platelet counts and lower levels of AT-III in the IBD group as compared with those in the control group. All other parameters of thrombophilia were comparable between the two groups.
format Text
id pubmed-2702936
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-27029362009-06-30 Assessment of Thrombophilic Abnormalities During the Active State of Inflammatory Bowel Disease Maher, Maha M. Soloma, Somaya H. Saudi J Gastroenterol Original Article BACKGROUND/AIMS: Thromboembolic disease has been recognized as a complication of inflammatory bowel disease (IBD). The relative contributions of inherited or acquired thrombophilia and the inflammatory response to the mechanism of this tendency are unclear. Thrombotic events are more common in active disease although significant numbers also occur spontaneously. The aim of this study was to investigate common thrombophilic markers in patients with active IBD. METHODS: Twenty-six patients with IBD who had active disease, and 40 sex- and age-matched non-IBD patients were recruited into the study. For all the subjects, complete blood counts, C-reactive protein levels, erythrocyte sedimentation rate, International normalized ratio, activated partial thromboplastin time, and levels of lupus anticoagulant, anticardiolipin antibodies (ACA IgG), proteins C and S, antithrombin-III (AT-III), and factor V were measured. RESULTS: The International normalized ratio, activated partial thromboplastin time, and levels of proteins C and S were comparable between the two groups. However, antithrombin-III levels were significantly lower in the IBD group as compared with that in the healthy control group (P < 0.001). ACA IgG was detected in one patient in the IBD group. Factor V Leiden mutation was present in 3.8% of the patients in the IBD group, whereas the prevalence was 2.5% in the control group. Significantly elevated platelet counts were observed in patients with active Crohn's disease compared with that in the control group (P < 0.001), but they were not significantly increased in active ulcerative colitis (P = 0.231). CONCLUSIONS: The present study failed to establish a strong association between the common thrombophilic markers and the active clinical course of IBD, with the exception of high platelet counts and lower levels of AT-III in the IBD group as compared with those in the control group. All other parameters of thrombophilia were comparable between the two groups. Medknow Publications 2008-10 /pmc/articles/PMC2702936/ /pubmed/19568537 http://dx.doi.org/10.4103/1319-3767.41743 Text en © The Saudi Journal of Gastroenterology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Maher, Maha M.
Soloma, Somaya H.
Assessment of Thrombophilic Abnormalities During the Active State of Inflammatory Bowel Disease
title Assessment of Thrombophilic Abnormalities During the Active State of Inflammatory Bowel Disease
title_full Assessment of Thrombophilic Abnormalities During the Active State of Inflammatory Bowel Disease
title_fullStr Assessment of Thrombophilic Abnormalities During the Active State of Inflammatory Bowel Disease
title_full_unstemmed Assessment of Thrombophilic Abnormalities During the Active State of Inflammatory Bowel Disease
title_short Assessment of Thrombophilic Abnormalities During the Active State of Inflammatory Bowel Disease
title_sort assessment of thrombophilic abnormalities during the active state of inflammatory bowel disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702936/
https://www.ncbi.nlm.nih.gov/pubmed/19568537
http://dx.doi.org/10.4103/1319-3767.41743
work_keys_str_mv AT mahermaham assessmentofthrombophilicabnormalitiesduringtheactivestateofinflammatoryboweldisease
AT solomasomayah assessmentofthrombophilicabnormalitiesduringtheactivestateofinflammatoryboweldisease